nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosutinib—P-Glycoprotein Inhibitors—Zonisamide—epilepsy syndrome	0.416	1	CiPCiCtD
Bosutinib—TYRO3—epilepsy syndrome	0.101	0.361	CbGaD
Bosutinib—FYN—epilepsy syndrome	0.0768	0.273	CbGaD
Bosutinib—PTK2B—epilepsy syndrome	0.0653	0.233	CbGaD
Bosutinib—SRC—epilepsy syndrome	0.031	0.111	CbGaD
Bosutinib—ABCB1—epilepsy syndrome	0.00634	0.0226	CbGaD
Bosutinib—ABCB1—Levetiracetam—epilepsy syndrome	0.00535	0.0906	CbGbCtD
Bosutinib—ABCB1—Clobazam—epilepsy syndrome	0.00371	0.0628	CbGbCtD
Bosutinib—ABCB1—Lamotrigine—epilepsy syndrome	0.00357	0.0605	CbGbCtD
Bosutinib—ABCB1—Carbamazepine—epilepsy syndrome	0.00307	0.0521	CbGbCtD
Bosutinib—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00293	0.0497	CbGbCtD
Bosutinib—ABCB1—Phenytoin—epilepsy syndrome	0.00276	0.0467	CbGbCtD
Bosutinib—CYP3A4—Felbamate—epilepsy syndrome	0.00273	0.0462	CbGbCtD
Bosutinib—CYP3A4—Trimethadione—epilepsy syndrome	0.00273	0.0462	CbGbCtD
Bosutinib—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00256	0.0434	CbGbCtD
Bosutinib—ABCB1—Phenobarbital—epilepsy syndrome	0.00246	0.0416	CbGbCtD
Bosutinib—ABCB1—Midazolam—epilepsy syndrome	0.00242	0.041	CbGbCtD
Bosutinib—ABCB1—Diazepam—epilepsy syndrome	0.00233	0.0394	CbGbCtD
Bosutinib—CYP3A4—Clonazepam—epilepsy syndrome	0.00232	0.0393	CbGbCtD
Bosutinib—CYP3A4—Clobazam—epilepsy syndrome	0.00222	0.0376	CbGbCtD
Bosutinib—CYP3A4—Rufinamide—epilepsy syndrome	0.00189	0.032	CbGbCtD
Bosutinib—CYP3A4—Carbamazepine—epilepsy syndrome	0.00184	0.0312	CbGbCtD
Bosutinib—CYP3A4—Primidone—epilepsy syndrome	0.00172	0.0291	CbGbCtD
Bosutinib—CYP3A4—Phenytoin—epilepsy syndrome	0.00165	0.028	CbGbCtD
Bosutinib—CYP3A4—Propofol—epilepsy syndrome	0.00154	0.0261	CbGbCtD
Bosutinib—CYP3A4—Acetazolamide—epilepsy syndrome	0.00147	0.0249	CbGbCtD
Bosutinib—CYP3A4—Phenobarbital—epilepsy syndrome	0.00147	0.0249	CbGbCtD
Bosutinib—CYP3A4—Midazolam—epilepsy syndrome	0.00145	0.0246	CbGbCtD
Bosutinib—CYP3A4—Diazepam—epilepsy syndrome	0.0014	0.0236	CbGbCtD
Bosutinib—CYP3A4—Zonisamide—epilepsy syndrome	0.00136	0.0231	CbGbCtD
Bosutinib—CYP3A4—Valproic Acid—epilepsy syndrome	0.0011	0.0186	CbGbCtD
Bosutinib—CYP3A4—Topiramate—epilepsy syndrome	0.000993	0.0168	CbGbCtD
Bosutinib—Vandetanib—TYRO3—epilepsy syndrome	0.000584	0.227	CrCbGaD
Bosutinib—Vandetanib—FYN—epilepsy syndrome	0.000443	0.172	CrCbGaD
Bosutinib—ERBB3—Bortezomib—Lacosamide—epilepsy syndrome	0.000372	0.52	CbGdCrCtD
Bosutinib—Vandetanib—TEK—epilepsy syndrome	0.000344	0.134	CrCbGaD
Bosutinib—CSK—Bortezomib—Lacosamide—epilepsy syndrome	0.000344	0.48	CbGdCrCtD
Bosutinib—Vandetanib—RET—epilepsy syndrome	0.00032	0.124	CrCbGaD
Bosutinib—Vandetanib—SRC—epilepsy syndrome	0.000179	0.0695	CrCbGaD
Bosutinib—Vandetanib—KDR—epilepsy syndrome	0.000168	0.0653	CrCbGaD
Bosutinib—Vandetanib—VEGFA—epilepsy syndrome	0.000143	0.0553	CrCbGaD
Bosutinib—Vandetanib—ABCG2—epilepsy syndrome	8.79e-05	0.0341	CrCbGaD
Bosutinib—Gefitinib—ABCG2—epilepsy syndrome	8.35e-05	0.0324	CrCbGaD
Bosutinib—MAP3K3—medulla oblongata—epilepsy syndrome	6.68e-05	0.00112	CbGeAlD
Bosutinib—AXL—midbrain—epilepsy syndrome	6.67e-05	0.00112	CbGeAlD
Bosutinib—BCR—central nervous system—epilepsy syndrome	6.66e-05	0.00112	CbGeAlD
Bosutinib—CSNK1A1—nervous system—epilepsy syndrome	6.64e-05	0.00112	CbGeAlD
Bosutinib—MAP3K12—central nervous system—epilepsy syndrome	6.61e-05	0.00111	CbGeAlD
Bosutinib—HCK—nervous system—epilepsy syndrome	6.6e-05	0.00111	CbGeAlD
Bosutinib—CLK1—nervous system—epilepsy syndrome	6.6e-05	0.00111	CbGeAlD
Bosutinib—PTK2B—head—epilepsy syndrome	6.6e-05	0.00111	CbGeAlD
Bosutinib—RPS6KB1—spinal cord—epilepsy syndrome	6.58e-05	0.00111	CbGeAlD
Bosutinib—Gefitinib—CYP2C19—epilepsy syndrome	6.57e-05	0.0255	CrCbGaD
Bosutinib—MAP4K4—cerebellum—epilepsy syndrome	6.56e-05	0.0011	CbGeAlD
Bosutinib—STK4—brain—epilepsy syndrome	6.53e-05	0.0011	CbGeAlD
Bosutinib—AXL—spinal cord—epilepsy syndrome	6.51e-05	0.00109	CbGeAlD
Bosutinib—BCR—cerebellum—epilepsy syndrome	6.51e-05	0.00109	CbGeAlD
Bosutinib—NUAK2—cerebellum—epilepsy syndrome	6.51e-05	0.00109	CbGeAlD
Bosutinib—CSNK1E—head—epilepsy syndrome	6.49e-05	0.00109	CbGeAlD
Bosutinib—MAP2K1—central nervous system—epilepsy syndrome	6.48e-05	0.00109	CbGeAlD
Bosutinib—STK35—central nervous system—epilepsy syndrome	6.48e-05	0.00109	CbGeAlD
Bosutinib—CAMK2G—nervous system—epilepsy syndrome	6.48e-05	0.00109	CbGeAlD
Bosutinib—BMP2K—nervous system—epilepsy syndrome	6.48e-05	0.00109	CbGeAlD
Bosutinib—MAP3K12—cerebellum—epilepsy syndrome	6.47e-05	0.00109	CbGeAlD
Bosutinib—CAMK1D—brain—epilepsy syndrome	6.46e-05	0.00109	CbGeAlD
Bosutinib—CSK—central nervous system—epilepsy syndrome	6.44e-05	0.00108	CbGeAlD
Bosutinib—SLK—midbrain—epilepsy syndrome	6.42e-05	0.00108	CbGeAlD
Bosutinib—LRRK2—nervous system—epilepsy syndrome	6.42e-05	0.00108	CbGeAlD
Bosutinib—CSNK1A1—central nervous system—epilepsy syndrome	6.4e-05	0.00108	CbGeAlD
Bosutinib—SIK1—head—epilepsy syndrome	6.39e-05	0.00107	CbGeAlD
Bosutinib—IRAK4—head—epilepsy syndrome	6.39e-05	0.00107	CbGeAlD
Bosutinib—STK24—brain—epilepsy syndrome	6.38e-05	0.00107	CbGeAlD
Bosutinib—EPHB4—midbrain—epilepsy syndrome	6.38e-05	0.00107	CbGeAlD
Bosutinib—HCK—central nervous system—epilepsy syndrome	6.36e-05	0.00107	CbGeAlD
Bosutinib—CLK1—central nervous system—epilepsy syndrome	6.36e-05	0.00107	CbGeAlD
Bosutinib—MAP2K1—cerebellum—epilepsy syndrome	6.33e-05	0.00106	CbGeAlD
Bosutinib—STK35—cerebellum—epilepsy syndrome	6.33e-05	0.00106	CbGeAlD
Bosutinib—EPHA4—head—epilepsy syndrome	6.33e-05	0.00106	CbGeAlD
Bosutinib—CSK—cerebellum—epilepsy syndrome	6.29e-05	0.00106	CbGeAlD
Bosutinib—SLK—spinal cord—epilepsy syndrome	6.27e-05	0.00105	CbGeAlD
Bosutinib—ERBB3—head—epilepsy syndrome	6.27e-05	0.00105	CbGeAlD
Bosutinib—PTK2B—nervous system—epilepsy syndrome	6.26e-05	0.00105	CbGeAlD
Bosutinib—CSNK1A1—cerebellum—epilepsy syndrome	6.25e-05	0.00105	CbGeAlD
Bosutinib—MAP2K2—head—epilepsy syndrome	6.25e-05	0.00105	CbGeAlD
Bosutinib—ULK3—head—epilepsy syndrome	6.25e-05	0.00105	CbGeAlD
Bosutinib—FYN—midbrain—epilepsy syndrome	6.25e-05	0.00105	CbGeAlD
Bosutinib—CAMK2G—central nervous system—epilepsy syndrome	6.24e-05	0.00105	CbGeAlD
Bosutinib—BMP2K—central nervous system—epilepsy syndrome	6.24e-05	0.00105	CbGeAlD
Bosutinib—EPHB4—spinal cord—epilepsy syndrome	6.22e-05	0.00105	CbGeAlD
Bosutinib—CLK1—cerebellum—epilepsy syndrome	6.21e-05	0.00104	CbGeAlD
Bosutinib—MAP3K2—head—epilepsy syndrome	6.21e-05	0.00104	CbGeAlD
Bosutinib—LRRK2—central nervous system—epilepsy syndrome	6.18e-05	0.00104	CbGeAlD
Bosutinib—FER—brain—epilepsy syndrome	6.18e-05	0.00104	CbGeAlD
Bosutinib—TYRO3—brain—epilepsy syndrome	6.18e-05	0.00104	CbGeAlD
Bosutinib—ALK—brain—epilepsy syndrome	6.18e-05	0.00104	CbGeAlD
Bosutinib—EPHA5—brain—epilepsy syndrome	6.18e-05	0.00104	CbGeAlD
Bosutinib—ABL2—cerebellum—epilepsy syndrome	6.17e-05	0.00104	CbGeAlD
Bosutinib—YES1—medulla oblongata—epilepsy syndrome	6.17e-05	0.00104	CbGeAlD
Bosutinib—CSNK1E—nervous system—epilepsy syndrome	6.16e-05	0.00103	CbGeAlD
Bosutinib—LYN—brain—epilepsy syndrome	6.14e-05	0.00103	CbGeAlD
Bosutinib—MAP4K5—midbrain—epilepsy syndrome	6.1e-05	0.00103	CbGeAlD
Bosutinib—MAP3K3—midbrain—epilepsy syndrome	6.1e-05	0.00103	CbGeAlD
Bosutinib—BMP2K—cerebellum—epilepsy syndrome	6.1e-05	0.00102	CbGeAlD
Bosutinib—CAMK2G—cerebellum—epilepsy syndrome	6.1e-05	0.00102	CbGeAlD
Bosutinib—FYN—spinal cord—epilepsy syndrome	6.09e-05	0.00102	CbGeAlD
Bosutinib—TAOK3—medulla oblongata—epilepsy syndrome	6.09e-05	0.00102	CbGeAlD
Bosutinib—PTK2—head—epilepsy syndrome	6.08e-05	0.00102	CbGeAlD
Bosutinib—TBK1—head—epilepsy syndrome	6.08e-05	0.00102	CbGeAlD
Bosutinib—SIK1—nervous system—epilepsy syndrome	6.06e-05	0.00102	CbGeAlD
Bosutinib—IRAK4—nervous system—epilepsy syndrome	6.06e-05	0.00102	CbGeAlD
Bosutinib—MAP3K19—brain—epilepsy syndrome	6.05e-05	0.00102	CbGeAlD
Bosutinib—MAP4K1—brain—epilepsy syndrome	6.05e-05	0.00102	CbGeAlD
Bosutinib—LRRK2—cerebellum—epilepsy syndrome	6.04e-05	0.00102	CbGeAlD
Bosutinib—ABL1—brainstem—epilepsy syndrome	6.04e-05	0.00102	CbGeAlD
Bosutinib—EGFR—cerebellum—epilepsy syndrome	6.02e-05	0.00101	CbGeAlD
Bosutinib—PTK2B—central nervous system—epilepsy syndrome	6.02e-05	0.00101	CbGeAlD
Bosutinib—BTK—brain—epilepsy syndrome	6.02e-05	0.00101	CbGeAlD
Bosutinib—PDGFRB—telencephalon—epilepsy syndrome	6.01e-05	0.00101	CbGeAlD
Bosutinib—EPHA4—nervous system—epilepsy syndrome	6e-05	0.00101	CbGeAlD
Bosutinib—MAP3K3—spinal cord—epilepsy syndrome	5.96e-05	0.001	CbGeAlD
Bosutinib—MAP4K5—spinal cord—epilepsy syndrome	5.96e-05	0.001	CbGeAlD
Bosutinib—ERBB3—nervous system—epilepsy syndrome	5.94e-05	0.000999	CbGeAlD
Bosutinib—TNK2—brain—epilepsy syndrome	5.93e-05	0.000997	CbGeAlD
Bosutinib—CSNK1E—central nervous system—epilepsy syndrome	5.93e-05	0.000996	CbGeAlD
Bosutinib—ULK3—nervous system—epilepsy syndrome	5.93e-05	0.000996	CbGeAlD
Bosutinib—MAP2K2—nervous system—epilepsy syndrome	5.93e-05	0.000996	CbGeAlD
Bosutinib—PTK2B—cerebellum—epilepsy syndrome	5.89e-05	0.00099	CbGeAlD
Bosutinib—MAP3K2—nervous system—epilepsy syndrome	5.88e-05	0.000989	CbGeAlD
Bosutinib—MAP4K2—brain—epilepsy syndrome	5.85e-05	0.000984	CbGeAlD
Bosutinib—RPS6KB1—head—epilepsy syndrome	5.85e-05	0.000983	CbGeAlD
Bosutinib—IRAK4—central nervous system—epilepsy syndrome	5.83e-05	0.000981	CbGeAlD
Bosutinib—SIK1—central nervous system—epilepsy syndrome	5.83e-05	0.000981	CbGeAlD
Bosutinib—FGR—head—epilepsy syndrome	5.81e-05	0.000977	CbGeAlD
Bosutinib—CSNK1E—cerebellum—epilepsy syndrome	5.79e-05	0.000974	CbGeAlD
Bosutinib—AXL—head—epilepsy syndrome	5.79e-05	0.000973	CbGeAlD
Bosutinib—EPHA4—central nervous system—epilepsy syndrome	5.78e-05	0.000971	CbGeAlD
Bosutinib—STK3—brain—epilepsy syndrome	5.77e-05	0.00097	CbGeAlD
Bosutinib—ERBB4—brain—epilepsy syndrome	5.77e-05	0.00097	CbGeAlD
Bosutinib—TBK1—nervous system—epilepsy syndrome	5.76e-05	0.000969	CbGeAlD
Bosutinib—PTK2—nervous system—epilepsy syndrome	5.76e-05	0.000969	CbGeAlD
Bosutinib—ERBB3—central nervous system—epilepsy syndrome	5.72e-05	0.000961	CbGeAlD
Bosutinib—MAP2K2—central nervous system—epilepsy syndrome	5.71e-05	0.000959	CbGeAlD
Bosutinib—ULK3—central nervous system—epilepsy syndrome	5.71e-05	0.000959	CbGeAlD
Bosutinib—IRAK4—cerebellum—epilepsy syndrome	5.7e-05	0.000959	CbGeAlD
Bosutinib—SIK1—cerebellum—epilepsy syndrome	5.7e-05	0.000959	CbGeAlD
Bosutinib—ROCK1—brain—epilepsy syndrome	5.7e-05	0.000958	CbGeAlD
Bosutinib—MAP3K2—central nervous system—epilepsy syndrome	5.66e-05	0.000952	CbGeAlD
Bosutinib—EPHA4—cerebellum—epilepsy syndrome	5.65e-05	0.000949	CbGeAlD
Bosutinib—YES1—midbrain—epilepsy syndrome	5.64e-05	0.000948	CbGeAlD
Bosutinib—ERBB3—cerebellum—epilepsy syndrome	5.59e-05	0.00094	CbGeAlD
Bosutinib—ULK3—cerebellum—epilepsy syndrome	5.58e-05	0.000937	CbGeAlD
Bosutinib—MAP2K2—cerebellum—epilepsy syndrome	5.58e-05	0.000937	CbGeAlD
Bosutinib—TAOK3—midbrain—epilepsy syndrome	5.57e-05	0.000936	CbGeAlD
Bosutinib—TBK1—central nervous system—epilepsy syndrome	5.55e-05	0.000932	CbGeAlD
Bosutinib—PTK2—central nervous system—epilepsy syndrome	5.55e-05	0.000932	CbGeAlD
Bosutinib—RPS6KB1—nervous system—epilepsy syndrome	5.54e-05	0.000932	CbGeAlD
Bosutinib—MAP3K2—cerebellum—epilepsy syndrome	5.54e-05	0.000931	CbGeAlD
Bosutinib—BMPR2—brain—epilepsy syndrome	5.53e-05	0.00093	CbGeAlD
Bosutinib—FGR—nervous system—epilepsy syndrome	5.51e-05	0.000926	CbGeAlD
Bosutinib—YES1—spinal cord—epilepsy syndrome	5.5e-05	0.000925	CbGeAlD
Bosutinib—STK36—brain—epilepsy syndrome	5.49e-05	0.000923	CbGeAlD
Bosutinib—EPHB3—brain—epilepsy syndrome	5.49e-05	0.000923	CbGeAlD
Bosutinib—AXL—nervous system—epilepsy syndrome	5.49e-05	0.000922	CbGeAlD
Bosutinib—MAP3K7—cerebellum—epilepsy syndrome	5.48e-05	0.000922	CbGeAlD
Bosutinib—MAP2K5—medulla oblongata—epilepsy syndrome	5.46e-05	0.000918	CbGeAlD
Bosutinib—TAOK3—spinal cord—epilepsy syndrome	5.43e-05	0.000913	CbGeAlD
Bosutinib—MERTK—brain—epilepsy syndrome	5.43e-05	0.000912	CbGeAlD
Bosutinib—EPHA2—head—epilepsy syndrome	5.43e-05	0.000912	CbGeAlD
Bosutinib—PTK2—cerebellum—epilepsy syndrome	5.42e-05	0.000911	CbGeAlD
Bosutinib—TBK1—cerebellum—epilepsy syndrome	5.42e-05	0.000911	CbGeAlD
Bosutinib—FYN—head—epilepsy syndrome	5.42e-05	0.000911	CbGeAlD
Bosutinib—ABL1—telencephalon—epilepsy syndrome	5.36e-05	0.000901	CbGeAlD
Bosutinib—RPS6KB1—central nervous system—epilepsy syndrome	5.34e-05	0.000897	CbGeAlD
Bosutinib—CSF1R—medulla oblongata—epilepsy syndrome	5.33e-05	0.000895	CbGeAlD
Bosutinib—MAP4K4—brain—epilepsy syndrome	5.33e-05	0.000895	CbGeAlD
Bosutinib—IRAK1—cerebellum—epilepsy syndrome	5.32e-05	0.000893	CbGeAlD
Bosutinib—FGR—central nervous system—epilepsy syndrome	5.3e-05	0.000892	CbGeAlD
Bosutinib—MAP3K3—head—epilepsy syndrome	5.29e-05	0.00089	CbGeAlD
Bosutinib—MAP4K5—head—epilepsy syndrome	5.29e-05	0.00089	CbGeAlD
Bosutinib—SRC—spinal cord—epilepsy syndrome	5.29e-05	0.000889	CbGeAlD
Bosutinib—NUAK2—brain—epilepsy syndrome	5.29e-05	0.000889	CbGeAlD
Bosutinib—BCR—brain—epilepsy syndrome	5.29e-05	0.000889	CbGeAlD
Bosutinib—AXL—central nervous system—epilepsy syndrome	5.28e-05	0.000888	CbGeAlD
Bosutinib—MAP3K12—brain—epilepsy syndrome	5.25e-05	0.000883	CbGeAlD
Bosutinib—RPS6KB1—cerebellum—epilepsy syndrome	5.22e-05	0.000877	CbGeAlD
Bosutinib—AXL—cerebellum—epilepsy syndrome	5.16e-05	0.000868	CbGeAlD
Bosutinib—MAP2K1—brain—epilepsy syndrome	5.14e-05	0.000865	CbGeAlD
Bosutinib—STK35—brain—epilepsy syndrome	5.14e-05	0.000865	CbGeAlD
Bosutinib—EPHA2—nervous system—epilepsy syndrome	5.14e-05	0.000865	CbGeAlD
Bosutinib—FYN—nervous system—epilepsy syndrome	5.14e-05	0.000863	CbGeAlD
Bosutinib—CSK—brain—epilepsy syndrome	5.11e-05	0.000859	CbGeAlD
Bosutinib—CSNK1A1—brain—epilepsy syndrome	5.08e-05	0.000854	CbGeAlD
Bosutinib—HCK—brain—epilepsy syndrome	5.05e-05	0.000848	CbGeAlD
Bosutinib—CLK1—brain—epilepsy syndrome	5.05e-05	0.000848	CbGeAlD
Bosutinib—MAP4K5—nervous system—epilepsy syndrome	5.02e-05	0.000844	CbGeAlD
Bosutinib—MAP3K3—nervous system—epilepsy syndrome	5.02e-05	0.000844	CbGeAlD
Bosutinib—ABL2—brain—epilepsy syndrome	5.01e-05	0.000843	CbGeAlD
Bosutinib—MAP2K5—midbrain—epilepsy syndrome	4.99e-05	0.000839	CbGeAlD
Bosutinib—SLK—cerebellum—epilepsy syndrome	4.97e-05	0.000835	CbGeAlD
Bosutinib—EPHA2—central nervous system—epilepsy syndrome	4.95e-05	0.000833	CbGeAlD
Bosutinib—BMP2K—brain—epilepsy syndrome	4.95e-05	0.000832	CbGeAlD
Bosutinib—CAMK2G—brain—epilepsy syndrome	4.95e-05	0.000832	CbGeAlD
Bosutinib—FYN—central nervous system—epilepsy syndrome	4.94e-05	0.000831	CbGeAlD
Bosutinib—EPHB4—cerebellum—epilepsy syndrome	4.93e-05	0.000829	CbGeAlD
Bosutinib—LRRK2—brain—epilepsy syndrome	4.91e-05	0.000825	CbGeAlD
Bosutinib—EGFR—brain—epilepsy syndrome	4.89e-05	0.000823	CbGeAlD
Bosutinib—YES1—head—epilepsy syndrome	4.89e-05	0.000822	CbGeAlD
Bosutinib—CSF1R—midbrain—epilepsy syndrome	4.87e-05	0.000818	CbGeAlD
Bosutinib—MAP2K5—spinal cord—epilepsy syndrome	4.87e-05	0.000818	CbGeAlD
Bosutinib—Gefitinib—CYP2D6—epilepsy syndrome	4.87e-05	0.0189	CrCbGaD
Bosutinib—STK10—head—epilepsy syndrome	4.84e-05	0.000814	CbGeAlD
Bosutinib—FYN—cerebellum—epilepsy syndrome	4.83e-05	0.000812	CbGeAlD
Bosutinib—MAP4K5—central nervous system—epilepsy syndrome	4.83e-05	0.000812	CbGeAlD
Bosutinib—MAP3K3—central nervous system—epilepsy syndrome	4.83e-05	0.000812	CbGeAlD
Bosutinib—TAOK3—head—epilepsy syndrome	4.83e-05	0.000811	CbGeAlD
Bosutinib—PTK2B—brain—epilepsy syndrome	4.78e-05	0.000804	CbGeAlD
Bosutinib—CSF1R—spinal cord—epilepsy syndrome	4.75e-05	0.000799	CbGeAlD
Bosutinib—PDGFRB—medulla oblongata—epilepsy syndrome	4.72e-05	0.000794	CbGeAlD
Bosutinib—MAP4K5—cerebellum—epilepsy syndrome	4.72e-05	0.000794	CbGeAlD
Bosutinib—MAP3K3—cerebellum—epilepsy syndrome	4.72e-05	0.000794	CbGeAlD
Bosutinib—CSNK1E—brain—epilepsy syndrome	4.71e-05	0.000791	CbGeAlD
Bosutinib—SRC—head—epilepsy syndrome	4.7e-05	0.000791	CbGeAlD
Bosutinib—YES1—nervous system—epilepsy syndrome	4.63e-05	0.000779	CbGeAlD
Bosutinib—IRAK4—brain—epilepsy syndrome	4.63e-05	0.000779	CbGeAlD
Bosutinib—SIK1—brain—epilepsy syndrome	4.63e-05	0.000779	CbGeAlD
Bosutinib—STK10—nervous system—epilepsy syndrome	4.59e-05	0.000772	CbGeAlD
Bosutinib—EPHA4—brain—epilepsy syndrome	4.59e-05	0.000771	CbGeAlD
Bosutinib—TAOK3—nervous system—epilepsy syndrome	4.58e-05	0.000769	CbGeAlD
Bosutinib—ERBB3—brain—epilepsy syndrome	4.54e-05	0.000763	CbGeAlD
Bosutinib—ULK3—brain—epilepsy syndrome	4.53e-05	0.000761	CbGeAlD
Bosutinib—MAP2K2—brain—epilepsy syndrome	4.53e-05	0.000761	CbGeAlD
Bosutinib—MAP3K2—brain—epilepsy syndrome	4.5e-05	0.000756	CbGeAlD
Bosutinib—YES1—central nervous system—epilepsy syndrome	4.46e-05	0.00075	CbGeAlD
Bosutinib—SRC—nervous system—epilepsy syndrome	4.46e-05	0.000749	CbGeAlD
Bosutinib—MAP3K7—brain—epilepsy syndrome	4.45e-05	0.000749	CbGeAlD
Bosutinib—STK10—central nervous system—epilepsy syndrome	4.42e-05	0.000743	CbGeAlD
Bosutinib—TAOK3—central nervous system—epilepsy syndrome	4.41e-05	0.00074	CbGeAlD
Bosutinib—PTK2—brain—epilepsy syndrome	4.4e-05	0.00074	CbGeAlD
Bosutinib—TBK1—brain—epilepsy syndrome	4.4e-05	0.00074	CbGeAlD
Bosutinib—YES1—cerebellum—epilepsy syndrome	4.36e-05	0.000733	CbGeAlD
Bosutinib—MAP2K5—head—epilepsy syndrome	4.33e-05	0.000727	CbGeAlD
Bosutinib—STK10—cerebellum—epilepsy syndrome	4.32e-05	0.000726	CbGeAlD
Bosutinib—PDGFRB—midbrain—epilepsy syndrome	4.32e-05	0.000726	CbGeAlD
Bosutinib—IRAK1—brain—epilepsy syndrome	4.32e-05	0.000726	CbGeAlD
Bosutinib—TAOK3—cerebellum—epilepsy syndrome	4.31e-05	0.000724	CbGeAlD
Bosutinib—SRC—central nervous system—epilepsy syndrome	4.29e-05	0.000722	CbGeAlD
Bosutinib—RPS6KB1—brain—epilepsy syndrome	4.24e-05	0.000712	CbGeAlD
Bosutinib—CSF1R—head—epilepsy syndrome	4.22e-05	0.00071	CbGeAlD
Bosutinib—PDGFRB—spinal cord—epilepsy syndrome	4.21e-05	0.000708	CbGeAlD
Bosutinib—ABL1—medulla oblongata—epilepsy syndrome	4.21e-05	0.000708	CbGeAlD
Bosutinib—FGR—brain—epilepsy syndrome	4.21e-05	0.000708	CbGeAlD
Bosutinib—SRC—cerebellum—epilepsy syndrome	4.2e-05	0.000705	CbGeAlD
Bosutinib—AXL—brain—epilepsy syndrome	4.19e-05	0.000705	CbGeAlD
Bosutinib—MAP2K5—nervous system—epilepsy syndrome	4.1e-05	0.000689	CbGeAlD
Bosutinib—SLK—brain—epilepsy syndrome	4.04e-05	0.000679	CbGeAlD
Bosutinib—Rash—Midazolam—epilepsy syndrome	4.01e-05	0.000495	CcSEcCtD
Bosutinib—Dizziness—Fosphenytoin—epilepsy syndrome	4.01e-05	0.000495	CcSEcCtD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	4.01e-05	0.000495	CcSEcCtD
Bosutinib—EPHB4—brain—epilepsy syndrome	4.01e-05	0.000674	CbGeAlD
Bosutinib—Dermatitis—Midazolam—epilepsy syndrome	4.01e-05	0.000495	CcSEcCtD
Bosutinib—CSF1R—nervous system—epilepsy syndrome	4e-05	0.000673	CbGeAlD
Bosutinib—Urticaria—Carbamazepine—epilepsy syndrome	4e-05	0.000494	CcSEcCtD
Bosutinib—Vomiting—Levetiracetam—epilepsy syndrome	4e-05	0.000493	CcSEcCtD
Bosutinib—Discomfort—Valproic Acid—epilepsy syndrome	3.99e-05	0.000492	CcSEcCtD
Bosutinib—Headache—Midazolam—epilepsy syndrome	3.99e-05	0.000492	CcSEcCtD
Bosutinib—Pruritus—Felbamate—epilepsy syndrome	3.98e-05	0.000492	CcSEcCtD
Bosutinib—Body temperature increased—Carbamazepine—epilepsy syndrome	3.98e-05	0.000492	CcSEcCtD
Bosutinib—Abdominal pain—Carbamazepine—epilepsy syndrome	3.98e-05	0.000492	CcSEcCtD
Bosutinib—Diarrhoea—Diazepam—epilepsy syndrome	3.98e-05	0.000491	CcSEcCtD
Bosutinib—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	3.98e-05	0.000491	CcSEcCtD
Bosutinib—Ill-defined disorder—Pregabalin—epilepsy syndrome	3.98e-05	0.000491	CcSEcCtD
Bosutinib—Rash—Levetiracetam—epilepsy syndrome	3.96e-05	0.000489	CcSEcCtD
Bosutinib—Anaemia—Pregabalin—epilepsy syndrome	3.96e-05	0.000489	CcSEcCtD
Bosutinib—Dermatitis—Levetiracetam—epilepsy syndrome	3.96e-05	0.000489	CcSEcCtD
Bosutinib—Asthenia—Zonisamide—epilepsy syndrome	3.96e-05	0.000488	CcSEcCtD
Bosutinib—MAP2K5—central nervous system—epilepsy syndrome	3.95e-05	0.000664	CbGeAlD
Bosutinib—Agranulocytosis—Topiramate—epilepsy syndrome	3.95e-05	0.000487	CcSEcCtD
Bosutinib—Headache—Levetiracetam—epilepsy syndrome	3.94e-05	0.000486	CcSEcCtD
Bosutinib—EPHA2—brain—epilepsy syndrome	3.93e-05	0.000661	CbGeAlD
Bosutinib—Malnutrition—Gabapentin—epilepsy syndrome	3.93e-05	0.000485	CcSEcCtD
Bosutinib—FYN—brain—epilepsy syndrome	3.93e-05	0.00066	CbGeAlD
Bosutinib—Dizziness—Vigabatrin—epilepsy syndrome	3.91e-05	0.000482	CcSEcCtD
Bosutinib—Pruritus—Zonisamide—epilepsy syndrome	3.9e-05	0.000481	CcSEcCtD
Bosutinib—Anaphylactic shock—Valproic Acid—epilepsy syndrome	3.87e-05	0.000478	CcSEcCtD
Bosutinib—Oedema—Valproic Acid—epilepsy syndrome	3.87e-05	0.000478	CcSEcCtD
Bosutinib—Urticaria—Lamotrigine—epilepsy syndrome	3.87e-05	0.000477	CcSEcCtD
Bosutinib—Malaise—Pregabalin—epilepsy syndrome	3.86e-05	0.000477	CcSEcCtD
Bosutinib—Nausea—Propofol—epilepsy syndrome	3.86e-05	0.000477	CcSEcCtD
Bosutinib—MAP2K5—cerebellum—epilepsy syndrome	3.86e-05	0.000649	CbGeAlD
Bosutinib—Vomiting—Fosphenytoin—epilepsy syndrome	3.86e-05	0.000476	CcSEcCtD
Bosutinib—CSF1R—central nervous system—epilepsy syndrome	3.85e-05	0.000648	CbGeAlD
Bosutinib—Diarrhoea—Felbamate—epilepsy syndrome	3.85e-05	0.000476	CcSEcCtD
Bosutinib—Abdominal pain—Lamotrigine—epilepsy syndrome	3.85e-05	0.000475	CcSEcCtD
Bosutinib—Body temperature increased—Lamotrigine—epilepsy syndrome	3.85e-05	0.000475	CcSEcCtD
Bosutinib—ABL1—midbrain—epilepsy syndrome	3.85e-05	0.000647	CbGeAlD
Bosutinib—Dysgeusia—Gabapentin—epilepsy syndrome	3.85e-05	0.000475	CcSEcCtD
Bosutinib—Dizziness—Diazepam—epilepsy syndrome	3.85e-05	0.000475	CcSEcCtD
Bosutinib—Infection—Valproic Acid—epilepsy syndrome	3.84e-05	0.000474	CcSEcCtD
Bosutinib—Leukopenia—Pregabalin—epilepsy syndrome	3.84e-05	0.000473	CcSEcCtD
Bosutinib—MAP4K5—brain—epilepsy syndrome	3.84e-05	0.000645	CbGeAlD
Bosutinib—MAP3K3—brain—epilepsy syndrome	3.84e-05	0.000645	CbGeAlD
Bosutinib—Vandetanib—ALB—epilepsy syndrome	3.83e-05	0.0149	CrCbGaD
Bosutinib—Rash—Fosphenytoin—epilepsy syndrome	3.82e-05	0.000472	CcSEcCtD
Bosutinib—Dermatitis—Fosphenytoin—epilepsy syndrome	3.82e-05	0.000471	CcSEcCtD
Bosutinib—Asthenia—Clonazepam—epilepsy syndrome	3.81e-05	0.000471	CcSEcCtD
Bosutinib—Back pain—Gabapentin—epilepsy syndrome	3.8e-05	0.000469	CcSEcCtD
Bosutinib—Headache—Fosphenytoin—epilepsy syndrome	3.8e-05	0.000469	CcSEcCtD
Bosutinib—Hepatitis—Topiramate—epilepsy syndrome	3.8e-05	0.000469	CcSEcCtD
Bosutinib—Nervous system disorder—Valproic Acid—epilepsy syndrome	3.79e-05	0.000468	CcSEcCtD
Bosutinib—Thrombocytopenia—Valproic Acid—epilepsy syndrome	3.79e-05	0.000468	CcSEcCtD
Bosutinib—Asthenia—Phenytoin—epilepsy syndrome	3.79e-05	0.000467	CcSEcCtD
Bosutinib—Nausea—Midazolam—epilepsy syndrome	3.78e-05	0.000466	CcSEcCtD
Bosutinib—Diarrhoea—Zonisamide—epilepsy syndrome	3.77e-05	0.000466	CcSEcCtD
Bosutinib—CSF1R—cerebellum—epilepsy syndrome	3.77e-05	0.000633	CbGeAlD
Bosutinib—Asthenia—Oxcarbazepine—epilepsy syndrome	3.77e-05	0.000465	CcSEcCtD
Bosutinib—Pruritus—Clonazepam—epilepsy syndrome	3.76e-05	0.000464	CcSEcCtD
Bosutinib—Vomiting—Vigabatrin—epilepsy syndrome	3.76e-05	0.000464	CcSEcCtD
Bosutinib—Skin disorder—Valproic Acid—epilepsy syndrome	3.76e-05	0.000464	CcSEcCtD
Bosutinib—ABL1—spinal cord—epilepsy syndrome	3.76e-05	0.000631	CbGeAlD
Bosutinib—Urinary tract disorder—Topiramate—epilepsy syndrome	3.75e-05	0.000463	CcSEcCtD
Bosutinib—PDGFRB—head—epilepsy syndrome	3.74e-05	0.000629	CbGeAlD
Bosutinib—Oedema peripheral—Topiramate—epilepsy syndrome	3.74e-05	0.000462	CcSEcCtD
Bosutinib—Cough—Pregabalin—epilepsy syndrome	3.74e-05	0.000462	CcSEcCtD
Bosutinib—Pruritus—Phenytoin—epilepsy syndrome	3.73e-05	0.000461	CcSEcCtD
Bosutinib—Connective tissue disorder—Topiramate—epilepsy syndrome	3.73e-05	0.000461	CcSEcCtD
Bosutinib—Nausea—Levetiracetam—epilepsy syndrome	3.73e-05	0.000461	CcSEcCtD
Bosutinib—Rash—Vigabatrin—epilepsy syndrome	3.73e-05	0.00046	CcSEcCtD
Bosutinib—Dizziness—Felbamate—epilepsy syndrome	3.72e-05	0.00046	CcSEcCtD
Bosutinib—Dermatitis—Vigabatrin—epilepsy syndrome	3.72e-05	0.00046	CcSEcCtD
Bosutinib—Urethral disorder—Topiramate—epilepsy syndrome	3.72e-05	0.00046	CcSEcCtD
Bosutinib—Pruritus—Oxcarbazepine—epilepsy syndrome	3.71e-05	0.000458	CcSEcCtD
Bosutinib—Headache—Vigabatrin—epilepsy syndrome	3.7e-05	0.000457	CcSEcCtD
Bosutinib—Vomiting—Diazepam—epilepsy syndrome	3.7e-05	0.000457	CcSEcCtD
Bosutinib—Rash—Diazepam—epilepsy syndrome	3.67e-05	0.000453	CcSEcCtD
Bosutinib—Dermatitis—Diazepam—epilepsy syndrome	3.67e-05	0.000452	CcSEcCtD
Bosutinib—Myalgia—Pregabalin—epilepsy syndrome	3.65e-05	0.00045	CcSEcCtD
Bosutinib—Chest pain—Pregabalin—epilepsy syndrome	3.65e-05	0.00045	CcSEcCtD
Bosutinib—Arthralgia—Pregabalin—epilepsy syndrome	3.65e-05	0.00045	CcSEcCtD
Bosutinib—Ill-defined disorder—Gabapentin—epilepsy syndrome	3.65e-05	0.00045	CcSEcCtD
Bosutinib—Dizziness—Zonisamide—epilepsy syndrome	3.65e-05	0.00045	CcSEcCtD
Bosutinib—Headache—Diazepam—epilepsy syndrome	3.65e-05	0.00045	CcSEcCtD
Bosutinib—Gefitinib—ALB—epilepsy syndrome	3.64e-05	0.0141	CrCbGaD
Bosutinib—Diarrhoea—Clonazepam—epilepsy syndrome	3.64e-05	0.000449	CcSEcCtD
Bosutinib—Anaemia—Gabapentin—epilepsy syndrome	3.63e-05	0.000448	CcSEcCtD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	3.62e-05	0.000447	CcSEcCtD
Bosutinib—Asthenia—Carbamazepine—epilepsy syndrome	3.61e-05	0.000446	CcSEcCtD
Bosutinib—Diarrhoea—Phenytoin—epilepsy syndrome	3.61e-05	0.000446	CcSEcCtD
Bosutinib—Discomfort—Pregabalin—epilepsy syndrome	3.61e-05	0.000445	CcSEcCtD
Bosutinib—Nausea—Fosphenytoin—epilepsy syndrome	3.6e-05	0.000445	CcSEcCtD
Bosutinib—Diarrhoea—Oxcarbazepine—epilepsy syndrome	3.59e-05	0.000443	CcSEcCtD
Bosutinib—Erythema multiforme—Topiramate—epilepsy syndrome	3.59e-05	0.000443	CcSEcCtD
Bosutinib—Vomiting—Felbamate—epilepsy syndrome	3.58e-05	0.000442	CcSEcCtD
Bosutinib—Pruritus—Carbamazepine—epilepsy syndrome	3.56e-05	0.00044	CcSEcCtD
Bosutinib—Rash—Felbamate—epilepsy syndrome	3.55e-05	0.000438	CcSEcCtD
Bosutinib—PDGFRB—nervous system—epilepsy syndrome	3.55e-05	0.000597	CbGeAlD
Bosutinib—Dermatitis—Felbamate—epilepsy syndrome	3.55e-05	0.000438	CcSEcCtD
Bosutinib—Malaise—Gabapentin—epilepsy syndrome	3.54e-05	0.000437	CcSEcCtD
Bosutinib—YES1—brain—epilepsy syndrome	3.54e-05	0.000595	CbGeAlD
Bosutinib—Tinnitus—Topiramate—epilepsy syndrome	3.54e-05	0.000437	CcSEcCtD
Bosutinib—Headache—Felbamate—epilepsy syndrome	3.53e-05	0.000435	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	3.53e-05	0.000435	CcSEcCtD
Bosutinib—Cardiac disorder—Topiramate—epilepsy syndrome	3.53e-05	0.000435	CcSEcCtD
Bosutinib—Leukopenia—Gabapentin—epilepsy syndrome	3.52e-05	0.000434	CcSEcCtD
Bosutinib—Dizziness—Clonazepam—epilepsy syndrome	3.51e-05	0.000434	CcSEcCtD
Bosutinib—Nausea—Vigabatrin—epilepsy syndrome	3.51e-05	0.000433	CcSEcCtD
Bosutinib—STK10—brain—epilepsy syndrome	3.51e-05	0.00059	CbGeAlD
Bosutinib—Vomiting—Zonisamide—epilepsy syndrome	3.51e-05	0.000433	CcSEcCtD
Bosutinib—Oedema—Pregabalin—epilepsy syndrome	3.5e-05	0.000432	CcSEcCtD
Bosutinib—Anaphylactic shock—Pregabalin—epilepsy syndrome	3.5e-05	0.000432	CcSEcCtD
Bosutinib—TAOK3—brain—epilepsy syndrome	3.5e-05	0.000588	CbGeAlD
Bosutinib—Asthenia—Lamotrigine—epilepsy syndrome	3.49e-05	0.000431	CcSEcCtD
Bosutinib—Dizziness—Phenytoin—epilepsy syndrome	3.49e-05	0.000431	CcSEcCtD
Bosutinib—Rash—Zonisamide—epilepsy syndrome	3.48e-05	0.000429	CcSEcCtD
Bosutinib—Gefitinib—ABCB1—epilepsy syndrome	3.48e-05	0.0135	CrCbGaD
Bosutinib—Infection—Pregabalin—epilepsy syndrome	3.48e-05	0.000429	CcSEcCtD
Bosutinib—Dermatitis—Zonisamide—epilepsy syndrome	3.47e-05	0.000429	CcSEcCtD
Bosutinib—Dizziness—Oxcarbazepine—epilepsy syndrome	3.47e-05	0.000428	CcSEcCtD
Bosutinib—Nausea—Diazepam—epilepsy syndrome	3.46e-05	0.000427	CcSEcCtD
Bosutinib—Headache—Zonisamide—epilepsy syndrome	3.45e-05	0.000426	CcSEcCtD
Bosutinib—Dyspnoea—Valproic Acid—epilepsy syndrome	3.45e-05	0.000426	CcSEcCtD
Bosutinib—Diarrhoea—Carbamazepine—epilepsy syndrome	3.45e-05	0.000425	CcSEcCtD
Bosutinib—Pruritus—Lamotrigine—epilepsy syndrome	3.44e-05	0.000425	CcSEcCtD
Bosutinib—Immune system disorder—Topiramate—epilepsy syndrome	3.43e-05	0.000423	CcSEcCtD
Bosutinib—Nervous system disorder—Pregabalin—epilepsy syndrome	3.43e-05	0.000423	CcSEcCtD
Bosutinib—Cough—Gabapentin—epilepsy syndrome	3.43e-05	0.000423	CcSEcCtD
Bosutinib—Thrombocytopenia—Pregabalin—epilepsy syndrome	3.42e-05	0.000423	CcSEcCtD
Bosutinib—Mediastinal disorder—Topiramate—epilepsy syndrome	3.42e-05	0.000422	CcSEcCtD
Bosutinib—PDGFRB—central nervous system—epilepsy syndrome	3.42e-05	0.000575	CbGeAlD
Bosutinib—SRC—brain—epilepsy syndrome	3.41e-05	0.000573	CbGeAlD
Bosutinib—Skin disorder—Pregabalin—epilepsy syndrome	3.4e-05	0.000419	CcSEcCtD
Bosutinib—Vomiting—Clonazepam—epilepsy syndrome	3.38e-05	0.000417	CcSEcCtD
Bosutinib—Decreased appetite—Valproic Acid—epilepsy syndrome	3.36e-05	0.000415	CcSEcCtD
Bosutinib—Vomiting—Phenytoin—epilepsy syndrome	3.36e-05	0.000414	CcSEcCtD
Bosutinib—Rash—Clonazepam—epilepsy syndrome	3.35e-05	0.000413	CcSEcCtD
Bosutinib—Dermatitis—Clonazepam—epilepsy syndrome	3.35e-05	0.000413	CcSEcCtD
Bosutinib—Chest pain—Gabapentin—epilepsy syndrome	3.35e-05	0.000413	CcSEcCtD
Bosutinib—Arthralgia—Gabapentin—epilepsy syndrome	3.35e-05	0.000413	CcSEcCtD
Bosutinib—Myalgia—Gabapentin—epilepsy syndrome	3.35e-05	0.000413	CcSEcCtD
Bosutinib—Nausea—Felbamate—epilepsy syndrome	3.35e-05	0.000413	CcSEcCtD
Bosutinib—PDGFRB—cerebellum—epilepsy syndrome	3.34e-05	0.000562	CbGeAlD
Bosutinib—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	3.34e-05	0.000412	CcSEcCtD
Bosutinib—Vomiting—Oxcarbazepine—epilepsy syndrome	3.34e-05	0.000412	CcSEcCtD
Bosutinib—ABL1—head—epilepsy syndrome	3.34e-05	0.000561	CbGeAlD
Bosutinib—Fatigue—Valproic Acid—epilepsy syndrome	3.34e-05	0.000412	CcSEcCtD
Bosutinib—Dizziness—Carbamazepine—epilepsy syndrome	3.33e-05	0.000411	CcSEcCtD
Bosutinib—Diarrhoea—Lamotrigine—epilepsy syndrome	3.33e-05	0.000411	CcSEcCtD
Bosutinib—Headache—Clonazepam—epilepsy syndrome	3.33e-05	0.000411	CcSEcCtD
Bosutinib—Rash—Phenytoin—epilepsy syndrome	3.33e-05	0.000411	CcSEcCtD
Bosutinib—Dermatitis—Phenytoin—epilepsy syndrome	3.32e-05	0.00041	CcSEcCtD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	3.32e-05	0.00041	CcSEcCtD
Bosutinib—Rash—Oxcarbazepine—epilepsy syndrome	3.31e-05	0.000409	CcSEcCtD
Bosutinib—Pain—Valproic Acid—epilepsy syndrome	3.31e-05	0.000408	CcSEcCtD
Bosutinib—Dermatitis—Oxcarbazepine—epilepsy syndrome	3.31e-05	0.000408	CcSEcCtD
Bosutinib—Headache—Phenytoin—epilepsy syndrome	3.31e-05	0.000408	CcSEcCtD
Bosutinib—Malnutrition—Topiramate—epilepsy syndrome	3.31e-05	0.000408	CcSEcCtD
Bosutinib—Discomfort—Gabapentin—epilepsy syndrome	3.31e-05	0.000408	CcSEcCtD
Bosutinib—Headache—Oxcarbazepine—epilepsy syndrome	3.29e-05	0.000406	CcSEcCtD
Bosutinib—Nausea—Zonisamide—epilepsy syndrome	3.27e-05	0.000404	CcSEcCtD
Bosutinib—Dysgeusia—Topiramate—epilepsy syndrome	3.24e-05	0.0004	CcSEcCtD
Bosutinib—Dizziness—Lamotrigine—epilepsy syndrome	3.22e-05	0.000397	CcSEcCtD
Bosutinib—Oedema—Gabapentin—epilepsy syndrome	3.21e-05	0.000396	CcSEcCtD
Bosutinib—Anaphylactic shock—Gabapentin—epilepsy syndrome	3.21e-05	0.000396	CcSEcCtD
Bosutinib—Vomiting—Carbamazepine—epilepsy syndrome	3.2e-05	0.000395	CcSEcCtD
Bosutinib—Back pain—Topiramate—epilepsy syndrome	3.2e-05	0.000395	CcSEcCtD
Bosutinib—Feeling abnormal—Valproic Acid—epilepsy syndrome	3.19e-05	0.000394	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	3.19e-05	0.000393	CcSEcCtD
Bosutinib—Infection—Gabapentin—epilepsy syndrome	3.19e-05	0.000393	CcSEcCtD
Bosutinib—Rash—Carbamazepine—epilepsy syndrome	3.18e-05	0.000392	CcSEcCtD
Bosutinib—Dermatitis—Carbamazepine—epilepsy syndrome	3.17e-05	0.000392	CcSEcCtD
Bosutinib—ABL1—nervous system—epilepsy syndrome	3.16e-05	0.000532	CbGeAlD
Bosutinib—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	3.16e-05	0.00039	CcSEcCtD
Bosutinib—Nausea—Clonazepam—epilepsy syndrome	3.16e-05	0.00039	CcSEcCtD
Bosutinib—Headache—Carbamazepine—epilepsy syndrome	3.16e-05	0.00039	CcSEcCtD
Bosutinib—Nervous system disorder—Gabapentin—epilepsy syndrome	3.15e-05	0.000388	CcSEcCtD
Bosutinib—Thrombocytopenia—Gabapentin—epilepsy syndrome	3.14e-05	0.000388	CcSEcCtD
Bosutinib—MAP2K5—brain—epilepsy syndrome	3.14e-05	0.000527	CbGeAlD
Bosutinib—Nausea—Phenytoin—epilepsy syndrome	3.13e-05	0.000387	CcSEcCtD
Bosutinib—Dyspnoea—Pregabalin—epilepsy syndrome	3.12e-05	0.000385	CcSEcCtD
Bosutinib—Nausea—Oxcarbazepine—epilepsy syndrome	3.12e-05	0.000385	CcSEcCtD
Bosutinib—Skin disorder—Gabapentin—epilepsy syndrome	3.12e-05	0.000385	CcSEcCtD
Bosutinib—Vomiting—Lamotrigine—epilepsy syndrome	3.1e-05	0.000382	CcSEcCtD
Bosutinib—Urticaria—Valproic Acid—epilepsy syndrome	3.07e-05	0.000379	CcSEcCtD
Bosutinib—Rash—Lamotrigine—epilepsy syndrome	3.07e-05	0.000379	CcSEcCtD
Bosutinib—Ill-defined disorder—Topiramate—epilepsy syndrome	3.07e-05	0.000379	CcSEcCtD
Bosutinib—Dermatitis—Lamotrigine—epilepsy syndrome	3.07e-05	0.000379	CcSEcCtD
Bosutinib—CSF1R—brain—epilepsy syndrome	3.06e-05	0.000514	CbGeAlD
Bosutinib—Abdominal pain—Valproic Acid—epilepsy syndrome	3.06e-05	0.000378	CcSEcCtD
Bosutinib—Body temperature increased—Valproic Acid—epilepsy syndrome	3.06e-05	0.000378	CcSEcCtD
Bosutinib—Anaemia—Topiramate—epilepsy syndrome	3.06e-05	0.000377	CcSEcCtD
Bosutinib—Headache—Lamotrigine—epilepsy syndrome	3.05e-05	0.000376	CcSEcCtD
Bosutinib—ABL1—central nervous system—epilepsy syndrome	3.05e-05	0.000512	CbGeAlD
Bosutinib—Decreased appetite—Pregabalin—epilepsy syndrome	3.04e-05	0.000375	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	3.02e-05	0.000373	CcSEcCtD
Bosutinib—Fatigue—Pregabalin—epilepsy syndrome	3.02e-05	0.000372	CcSEcCtD
Bosutinib—Nausea—Carbamazepine—epilepsy syndrome	2.99e-05	0.000369	CcSEcCtD
Bosutinib—Pain—Pregabalin—epilepsy syndrome	2.99e-05	0.000369	CcSEcCtD
Bosutinib—Malaise—Topiramate—epilepsy syndrome	2.98e-05	0.000368	CcSEcCtD
Bosutinib—ABL1—cerebellum—epilepsy syndrome	2.98e-05	0.000501	CbGeAlD
Bosutinib—Leukopenia—Topiramate—epilepsy syndrome	2.96e-05	0.000365	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	2.92e-05	0.000361	CcSEcCtD
Bosutinib—Nausea—Lamotrigine—epilepsy syndrome	2.89e-05	0.000357	CcSEcCtD
Bosutinib—Cough—Topiramate—epilepsy syndrome	2.89e-05	0.000356	CcSEcCtD
Bosutinib—Feeling abnormal—Pregabalin—epilepsy syndrome	2.88e-05	0.000356	CcSEcCtD
Bosutinib—Gastrointestinal pain—Pregabalin—epilepsy syndrome	2.86e-05	0.000353	CcSEcCtD
Bosutinib—Dyspnoea—Gabapentin—epilepsy syndrome	2.86e-05	0.000353	CcSEcCtD
Bosutinib—Arthralgia—Topiramate—epilepsy syndrome	2.81e-05	0.000347	CcSEcCtD
Bosutinib—Chest pain—Topiramate—epilepsy syndrome	2.81e-05	0.000347	CcSEcCtD
Bosutinib—Myalgia—Topiramate—epilepsy syndrome	2.81e-05	0.000347	CcSEcCtD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	2.8e-05	0.000345	CcSEcCtD
Bosutinib—Decreased appetite—Gabapentin—epilepsy syndrome	2.79e-05	0.000344	CcSEcCtD
Bosutinib—Discomfort—Topiramate—epilepsy syndrome	2.78e-05	0.000343	CcSEcCtD
Bosutinib—Urticaria—Pregabalin—epilepsy syndrome	2.78e-05	0.000343	CcSEcCtD
Bosutinib—Asthenia—Valproic Acid—epilepsy syndrome	2.78e-05	0.000343	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	2.77e-05	0.000342	CcSEcCtD
Bosutinib—Fatigue—Gabapentin—epilepsy syndrome	2.77e-05	0.000341	CcSEcCtD
Bosutinib—Abdominal pain—Pregabalin—epilepsy syndrome	2.77e-05	0.000341	CcSEcCtD
Bosutinib—Body temperature increased—Pregabalin—epilepsy syndrome	2.77e-05	0.000341	CcSEcCtD
Bosutinib—Pain—Gabapentin—epilepsy syndrome	2.74e-05	0.000339	CcSEcCtD
Bosutinib—Pruritus—Valproic Acid—epilepsy syndrome	2.74e-05	0.000338	CcSEcCtD
Bosutinib—PDGFRB—brain—epilepsy syndrome	2.71e-05	0.000456	CbGeAlD
Bosutinib—Oedema—Topiramate—epilepsy syndrome	2.7e-05	0.000333	CcSEcCtD
Bosutinib—Infection—Topiramate—epilepsy syndrome	2.68e-05	0.000331	CcSEcCtD
Bosutinib—Diarrhoea—Valproic Acid—epilepsy syndrome	2.65e-05	0.000327	CcSEcCtD
Bosutinib—Nervous system disorder—Topiramate—epilepsy syndrome	2.65e-05	0.000327	CcSEcCtD
Bosutinib—Feeling abnormal—Gabapentin—epilepsy syndrome	2.64e-05	0.000326	CcSEcCtD
Bosutinib—Thrombocytopenia—Topiramate—epilepsy syndrome	2.64e-05	0.000326	CcSEcCtD
Bosutinib—Gastrointestinal pain—Gabapentin—epilepsy syndrome	2.62e-05	0.000324	CcSEcCtD
Bosutinib—Skin disorder—Topiramate—epilepsy syndrome	2.62e-05	0.000324	CcSEcCtD
Bosutinib—Dizziness—Valproic Acid—epilepsy syndrome	2.56e-05	0.000316	CcSEcCtD
Bosutinib—Urticaria—Gabapentin—epilepsy syndrome	2.55e-05	0.000314	CcSEcCtD
Bosutinib—Abdominal pain—Gabapentin—epilepsy syndrome	2.54e-05	0.000313	CcSEcCtD
Bosutinib—Body temperature increased—Gabapentin—epilepsy syndrome	2.54e-05	0.000313	CcSEcCtD
Bosutinib—Asthenia—Pregabalin—epilepsy syndrome	2.51e-05	0.00031	CcSEcCtD
Bosutinib—Pruritus—Pregabalin—epilepsy syndrome	2.47e-05	0.000305	CcSEcCtD
Bosutinib—Vomiting—Valproic Acid—epilepsy syndrome	2.46e-05	0.000304	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	2.46e-05	0.000303	CcSEcCtD
Bosutinib—Rash—Valproic Acid—epilepsy syndrome	2.44e-05	0.000301	CcSEcCtD
Bosutinib—Dermatitis—Valproic Acid—epilepsy syndrome	2.44e-05	0.000301	CcSEcCtD
Bosutinib—Headache—Valproic Acid—epilepsy syndrome	2.42e-05	0.000299	CcSEcCtD
Bosutinib—ABL1—brain—epilepsy syndrome	2.42e-05	0.000407	CbGeAlD
Bosutinib—Dyspnoea—Topiramate—epilepsy syndrome	2.41e-05	0.000297	CcSEcCtD
Bosutinib—Diarrhoea—Pregabalin—epilepsy syndrome	2.39e-05	0.000295	CcSEcCtD
Bosutinib—Decreased appetite—Topiramate—epilepsy syndrome	2.35e-05	0.00029	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Topiramate—epilepsy syndrome	2.33e-05	0.000288	CcSEcCtD
Bosutinib—Fatigue—Topiramate—epilepsy syndrome	2.33e-05	0.000287	CcSEcCtD
Bosutinib—Dizziness—Pregabalin—epilepsy syndrome	2.31e-05	0.000285	CcSEcCtD
Bosutinib—Pain—Topiramate—epilepsy syndrome	2.31e-05	0.000285	CcSEcCtD
Bosutinib—Asthenia—Gabapentin—epilepsy syndrome	2.3e-05	0.000284	CcSEcCtD
Bosutinib—Nausea—Valproic Acid—epilepsy syndrome	2.3e-05	0.000284	CcSEcCtD
Bosutinib—Pruritus—Gabapentin—epilepsy syndrome	2.27e-05	0.00028	CcSEcCtD
Bosutinib—Vomiting—Pregabalin—epilepsy syndrome	2.22e-05	0.000274	CcSEcCtD
Bosutinib—Feeling abnormal—Topiramate—epilepsy syndrome	2.22e-05	0.000274	CcSEcCtD
Bosutinib—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.21e-05	0.000272	CcSEcCtD
Bosutinib—Rash—Pregabalin—epilepsy syndrome	2.21e-05	0.000272	CcSEcCtD
Bosutinib—Dermatitis—Pregabalin—epilepsy syndrome	2.2e-05	0.000272	CcSEcCtD
Bosutinib—Diarrhoea—Gabapentin—epilepsy syndrome	2.19e-05	0.000271	CcSEcCtD
Bosutinib—Headache—Pregabalin—epilepsy syndrome	2.19e-05	0.00027	CcSEcCtD
Bosutinib—Urticaria—Topiramate—epilepsy syndrome	2.14e-05	0.000265	CcSEcCtD
Bosutinib—Abdominal pain—Topiramate—epilepsy syndrome	2.13e-05	0.000263	CcSEcCtD
Bosutinib—Body temperature increased—Topiramate—epilepsy syndrome	2.13e-05	0.000263	CcSEcCtD
Bosutinib—Dizziness—Gabapentin—epilepsy syndrome	2.12e-05	0.000262	CcSEcCtD
Bosutinib—Nausea—Pregabalin—epilepsy syndrome	2.08e-05	0.000256	CcSEcCtD
Bosutinib—Vomiting—Gabapentin—epilepsy syndrome	2.04e-05	0.000252	CcSEcCtD
Bosutinib—Rash—Gabapentin—epilepsy syndrome	2.02e-05	0.00025	CcSEcCtD
Bosutinib—Dermatitis—Gabapentin—epilepsy syndrome	2.02e-05	0.000249	CcSEcCtD
Bosutinib—Headache—Gabapentin—epilepsy syndrome	2.01e-05	0.000248	CcSEcCtD
Bosutinib—Asthenia—Topiramate—epilepsy syndrome	1.94e-05	0.000239	CcSEcCtD
Bosutinib—Pruritus—Topiramate—epilepsy syndrome	1.91e-05	0.000236	CcSEcCtD
Bosutinib—Nausea—Gabapentin—epilepsy syndrome	1.91e-05	0.000235	CcSEcCtD
Bosutinib—Diarrhoea—Topiramate—epilepsy syndrome	1.85e-05	0.000228	CcSEcCtD
Bosutinib—ABCB1—forebrain—epilepsy syndrome	1.81e-05	0.000305	CbGeAlD
Bosutinib—Dizziness—Topiramate—epilepsy syndrome	1.78e-05	0.00022	CcSEcCtD
Bosutinib—Vomiting—Topiramate—epilepsy syndrome	1.72e-05	0.000212	CcSEcCtD
Bosutinib—Rash—Topiramate—epilepsy syndrome	1.7e-05	0.00021	CcSEcCtD
Bosutinib—Dermatitis—Topiramate—epilepsy syndrome	1.7e-05	0.00021	CcSEcCtD
Bosutinib—Headache—Topiramate—epilepsy syndrome	1.69e-05	0.000209	CcSEcCtD
Bosutinib—ABCB1—telencephalon—epilepsy syndrome	1.67e-05	0.00028	CbGeAlD
Bosutinib—Nausea—Topiramate—epilepsy syndrome	1.6e-05	0.000198	CcSEcCtD
Bosutinib—CYP3A4—nervous system—epilepsy syndrome	1.39e-05	0.000234	CbGeAlD
Bosutinib—CYP3A4—central nervous system—epilepsy syndrome	1.34e-05	0.000225	CbGeAlD
Bosutinib—ABCB1—medulla oblongata—epilepsy syndrome	1.31e-05	0.00022	CbGeAlD
Bosutinib—ABCB1—midbrain—epilepsy syndrome	1.2e-05	0.000201	CbGeAlD
Bosutinib—ABCB1—spinal cord—epilepsy syndrome	1.17e-05	0.000196	CbGeAlD
Bosutinib—ABCB1—head—epilepsy syndrome	1.04e-05	0.000174	CbGeAlD
Bosutinib—ABCB1—nervous system—epilepsy syndrome	9.84e-06	0.000165	CbGeAlD
Bosutinib—ABCB1—central nervous system—epilepsy syndrome	9.47e-06	0.000159	CbGeAlD
Bosutinib—ABCB1—cerebellum—epilepsy syndrome	9.26e-06	0.000156	CbGeAlD
Bosutinib—ABCB1—brain—epilepsy syndrome	7.52e-06	0.000126	CbGeAlD
Bosutinib—EGFR—Signaling Pathways—AGT—epilepsy syndrome	2.39e-07	2.38e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—CASP3—epilepsy syndrome	2.39e-07	2.37e-06	CbGpPWpGaD
Bosutinib—FYN—Adaptive Immune System—AKT1—epilepsy syndrome	2.38e-07	2.37e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—FYN—epilepsy syndrome	2.38e-07	2.36e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—AQP1—epilepsy syndrome	2.37e-07	2.36e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—H2AFX—epilepsy syndrome	2.37e-07	2.35e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—POMC—epilepsy syndrome	2.37e-07	2.35e-06	CbGpPWpGaD
Bosutinib—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	2.37e-07	2.35e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—CCL2—epilepsy syndrome	2.37e-07	2.35e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—MEF2C—epilepsy syndrome	2.37e-07	2.35e-06	CbGpPWpGaD
Bosutinib—LYN—Immune System—SRC—epilepsy syndrome	2.36e-07	2.35e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	2.36e-07	2.35e-06	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—VEGFA—epilepsy syndrome	2.36e-07	2.34e-06	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—VEGFA—epilepsy syndrome	2.36e-07	2.34e-06	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—AKT1—epilepsy syndrome	2.36e-07	2.34e-06	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—AKT1—epilepsy syndrome	2.36e-07	2.34e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—BCHE—epilepsy syndrome	2.35e-07	2.34e-06	CbGpPWpGaD
Bosutinib—ABL1—Immune System—SRC—epilepsy syndrome	2.35e-07	2.34e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—CASP3—epilepsy syndrome	2.35e-07	2.33e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—FGF2—epilepsy syndrome	2.35e-07	2.33e-06	CbGpPWpGaD
Bosutinib—ERBB4—Disease—AKT1—epilepsy syndrome	2.35e-07	2.33e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—APOE—epilepsy syndrome	2.35e-07	2.33e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—SRC—epilepsy syndrome	2.33e-07	2.32e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—POMC—epilepsy syndrome	2.33e-07	2.31e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—RELA—epilepsy syndrome	2.33e-07	2.31e-06	CbGpPWpGaD
Bosutinib—FYN—Immune System—SRC—epilepsy syndrome	2.33e-07	2.31e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—POMC—epilepsy syndrome	2.32e-07	2.3e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—CCL2—epilepsy syndrome	2.32e-07	2.3e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—JUN—epilepsy syndrome	2.32e-07	2.3e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—MTOR—epilepsy syndrome	2.32e-07	2.3e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—SRC—epilepsy syndrome	2.31e-07	2.3e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—IL1B—epilepsy syndrome	2.31e-07	2.3e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—TSC2—epilepsy syndrome	2.31e-07	2.29e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—AGT—epilepsy syndrome	2.31e-07	2.29e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—KDR—epilepsy syndrome	2.3e-07	2.28e-06	CbGpPWpGaD
Bosutinib—LCK—Hemostasis—AKT1—epilepsy syndrome	2.3e-07	2.28e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—PTGS2—epilepsy syndrome	2.3e-07	2.28e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—YWHAZ—epilepsy syndrome	2.29e-07	2.27e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—JUN—epilepsy syndrome	2.28e-07	2.27e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—SRC—epilepsy syndrome	2.28e-07	2.27e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—MTOR—epilepsy syndrome	2.28e-07	2.27e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—CCL2—epilepsy syndrome	2.28e-07	2.27e-06	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—AKT1—epilepsy syndrome	2.28e-07	2.26e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—VEGFA—epilepsy syndrome	2.27e-07	2.26e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—CCL2—epilepsy syndrome	2.27e-07	2.25e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—NGF—epilepsy syndrome	2.26e-07	2.24e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—APOE—epilepsy syndrome	2.26e-07	2.24e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—MMP9—epilepsy syndrome	2.25e-07	2.24e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	2.25e-07	2.23e-06	CbGpPWpGaD
Bosutinib—ERBB3—Immune System—AKT1—epilepsy syndrome	2.24e-07	2.23e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—JUN—epilepsy syndrome	2.24e-07	2.22e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—BCL2—epilepsy syndrome	2.23e-07	2.22e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—MTOR—epilepsy syndrome	2.23e-07	2.22e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—CASP3—epilepsy syndrome	2.23e-07	2.21e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—SRC—epilepsy syndrome	2.23e-07	2.21e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—IL1B—epilepsy syndrome	2.23e-07	2.21e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—MMP9—epilepsy syndrome	2.22e-07	2.21e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—PLCB1—epilepsy syndrome	2.22e-07	2.2e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—KDR—epilepsy syndrome	2.21e-07	2.2e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—TH—epilepsy syndrome	2.21e-07	2.2e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—PRKCB—epilepsy syndrome	2.21e-07	2.2e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—PTGS2—epilepsy syndrome	2.21e-07	2.2e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—IL6ST—epilepsy syndrome	2.2e-07	2.19e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CCR5—epilepsy syndrome	2.2e-07	2.18e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—FGF2—epilepsy syndrome	2.19e-07	2.18e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—RELA—epilepsy syndrome	2.18e-07	2.17e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—FGF2—epilepsy syndrome	2.17e-07	2.15e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—JUN—epilepsy syndrome	2.17e-07	2.15e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—JUN—epilepsy syndrome	2.16e-07	2.14e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—HTR2A—epilepsy syndrome	2.15e-07	2.14e-06	CbGpPWpGaD
Bosutinib—FYN—Disease—SRC—epilepsy syndrome	2.15e-07	2.13e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	2.15e-07	2.13e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	2.15e-07	2.13e-06	CbGpPWpGaD
Bosutinib—EGFR—Innate Immune System—AKT1—epilepsy syndrome	2.15e-07	2.13e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—MTOR—epilepsy syndrome	2.14e-07	2.12e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—FGF2—epilepsy syndrome	2.14e-07	2.12e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—SRC—epilepsy syndrome	2.14e-07	2.12e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—PRKCB—epilepsy syndrome	2.13e-07	2.12e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—IL6ST—epilepsy syndrome	2.12e-07	2.11e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—MMP9—epilepsy syndrome	2.11e-07	2.09e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—CASP3—epilepsy syndrome	2.1e-07	2.09e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—FGF2—epilepsy syndrome	2.09e-07	2.08e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—SRC—epilepsy syndrome	2.08e-07	2.06e-06	CbGpPWpGaD
Bosutinib—SRC—Developmental Biology—AKT1—epilepsy syndrome	2.07e-07	2.06e-06	CbGpPWpGaD
Bosutinib—ERBB3—Disease—AKT1—epilepsy syndrome	2.07e-07	2.06e-06	CbGpPWpGaD
Bosutinib—LCK—Innate Immune System—AKT1—epilepsy syndrome	2.07e-07	2.05e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—FGF2—epilepsy syndrome	2.06e-07	2.05e-06	CbGpPWpGaD
Bosutinib—EGFR—Adaptive Immune System—AKT1—epilepsy syndrome	2.06e-07	2.04e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—FGF2—epilepsy syndrome	2.05e-07	2.04e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—SRC—epilepsy syndrome	2.05e-07	2.03e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—TSC2—epilepsy syndrome	2.04e-07	2.03e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—AGT—epilepsy syndrome	2.04e-07	2.03e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—JUN—epilepsy syndrome	2.04e-07	2.03e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—RELA—epilepsy syndrome	2.04e-07	2.02e-06	CbGpPWpGaD
Bosutinib—SRC—Hemostasis—AKT1—epilepsy syndrome	2.03e-07	2.02e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—VEGFA—epilepsy syndrome	2.02e-07	2.01e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—POMC—epilepsy syndrome	2.01e-07	2e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—SRC—epilepsy syndrome	2.01e-07	2e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—APOE—epilepsy syndrome	2e-07	1.99e-06	CbGpPWpGaD
Bosutinib—PTK2—Immune System—AKT1—epilepsy syndrome	2e-07	1.98e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—VEGFA—epilepsy syndrome	2e-07	1.98e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—MTOR—epilepsy syndrome	2e-07	1.98e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—RELA—epilepsy syndrome	1.99e-07	1.97e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—MMP9—epilepsy syndrome	1.99e-07	1.97e-06	CbGpPWpGaD
Bosutinib—LCK—Adaptive Immune System—AKT1—epilepsy syndrome	1.99e-07	1.97e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—MTOR—epilepsy syndrome	1.98e-07	1.96e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—IL1B—epilepsy syndrome	1.97e-07	1.96e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CCL2—epilepsy syndrome	1.97e-07	1.96e-06	CbGpPWpGaD
Bosutinib—YES1—Immune System—AKT1—epilepsy syndrome	1.97e-07	1.96e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—KDR—epilepsy syndrome	1.96e-07	1.95e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—PTGS2—epilepsy syndrome	1.96e-07	1.94e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—MTOR—epilepsy syndrome	1.95e-07	1.93e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—RELA—epilepsy syndrome	1.94e-07	1.93e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—SRC—epilepsy syndrome	1.94e-07	1.93e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—POMC—epilepsy syndrome	1.94e-07	1.93e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—SRC—epilepsy syndrome	1.94e-07	1.92e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—RELA—epilepsy syndrome	1.91e-07	1.9e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—JUN—epilepsy syndrome	1.91e-07	1.9e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—MTOR—epilepsy syndrome	1.91e-07	1.89e-06	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—AKT1—epilepsy syndrome	1.9e-07	1.89e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—RELA—epilepsy syndrome	1.9e-07	1.89e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CCL2—epilepsy syndrome	1.9e-07	1.89e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—VEGFA—epilepsy syndrome	1.89e-07	1.88e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—PRKCB—epilepsy syndrome	1.89e-07	1.87e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—IL6ST—epilepsy syndrome	1.88e-07	1.87e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—MTOR—epilepsy syndrome	1.88e-07	1.86e-06	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—AKT1—epilepsy syndrome	1.87e-07	1.85e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—MTOR—epilepsy syndrome	1.87e-07	1.85e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—SRC—epilepsy syndrome	1.86e-07	1.84e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—HMOX1—epilepsy syndrome	1.85e-07	1.83e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—CASP3—epilepsy syndrome	1.84e-07	1.82e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—SRC—epilepsy syndrome	1.83e-07	1.82e-06	CbGpPWpGaD
Bosutinib—SRC—Innate Immune System—AKT1—epilepsy syndrome	1.83e-07	1.82e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—CAT—epilepsy syndrome	1.82e-07	1.81e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—CASP3—epilepsy syndrome	1.79e-07	1.78e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—SRC—epilepsy syndrome	1.79e-07	1.78e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—JUN—epilepsy syndrome	1.78e-07	1.77e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—VEGFA—epilepsy syndrome	1.78e-07	1.77e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—FGF2—epilepsy syndrome	1.78e-07	1.77e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—AKT1—epilepsy syndrome	1.76e-07	1.75e-06	CbGpPWpGaD
Bosutinib—SRC—Adaptive Immune System—AKT1—epilepsy syndrome	1.76e-07	1.74e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—CASP3—epilepsy syndrome	1.75e-07	1.74e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.75e-07	1.74e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—JUN—epilepsy syndrome	1.74e-07	1.73e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—MMP9—epilepsy syndrome	1.73e-07	1.72e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—CASP3—epilepsy syndrome	1.73e-07	1.71e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—POMC—epilepsy syndrome	1.72e-07	1.71e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—CASP3—epilepsy syndrome	1.72e-07	1.7e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—FGF2—epilepsy syndrome	1.72e-07	1.7e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.71e-07	1.69e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—JUN—epilepsy syndrome	1.7e-07	1.69e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.69e-07	1.68e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—MMP9—epilepsy syndrome	1.69e-07	1.68e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—AKT1—epilepsy syndrome	1.68e-07	1.67e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CCL2—epilepsy syndrome	1.68e-07	1.67e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—JUN—epilepsy syndrome	1.68e-07	1.66e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—JUN—epilepsy syndrome	1.67e-07	1.66e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—MMP9—epilepsy syndrome	1.66e-07	1.65e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—RELA—epilepsy syndrome	1.65e-07	1.64e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—GPX1—epilepsy syndrome	1.65e-07	1.64e-06	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—AKT1—epilepsy syndrome	1.65e-07	1.63e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—MMP9—epilepsy syndrome	1.63e-07	1.62e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—MMP9—epilepsy syndrome	1.62e-07	1.61e-06	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—AKT1—epilepsy syndrome	1.62e-07	1.61e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—MTOR—epilepsy syndrome	1.62e-07	1.61e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—SRC—epilepsy syndrome	1.6e-07	1.59e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—RELA—epilepsy syndrome	1.59e-07	1.58e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—AKT1—epilepsy syndrome	1.57e-07	1.56e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—MTOR—epilepsy syndrome	1.56e-07	1.55e-06	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—AKT1—epilepsy syndrome	1.56e-07	1.55e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—SRC—epilepsy syndrome	1.56e-07	1.55e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—VEGFA—epilepsy syndrome	1.56e-07	1.55e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—AKT1—epilepsy syndrome	1.54e-07	1.53e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.53e-07	1.52e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—SRC—epilepsy syndrome	1.53e-07	1.52e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—VEGFA—epilepsy syndrome	1.52e-07	1.51e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—FGF2—epilepsy syndrome	1.52e-07	1.51e-06	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—AKT1—epilepsy syndrome	1.51e-07	1.49e-06	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—AKT1—epilepsy syndrome	1.51e-07	1.49e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—SRC—epilepsy syndrome	1.5e-07	1.49e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—AKT1—epilepsy syndrome	1.5e-07	1.49e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—SRC—epilepsy syndrome	1.5e-07	1.49e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CASP3—epilepsy syndrome	1.49e-07	1.48e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—VEGFA—epilepsy syndrome	1.49e-07	1.48e-06	CbGpPWpGaD
Bosutinib—LYN—Immune System—AKT1—epilepsy syndrome	1.47e-07	1.46e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—VEGFA—epilepsy syndrome	1.47e-07	1.45e-06	CbGpPWpGaD
Bosutinib—ABL1—Immune System—AKT1—epilepsy syndrome	1.46e-07	1.45e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—VEGFA—epilepsy syndrome	1.46e-07	1.45e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.46e-07	1.45e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—AKT1—epilepsy syndrome	1.45e-07	1.44e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.45e-07	1.44e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—JUN—epilepsy syndrome	1.45e-07	1.44e-06	CbGpPWpGaD
Bosutinib—FYN—Immune System—AKT1—epilepsy syndrome	1.45e-07	1.44e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—AGT—epilepsy syndrome	1.45e-07	1.43e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—AKT1—epilepsy syndrome	1.44e-07	1.43e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CASP3—epilepsy syndrome	1.44e-07	1.43e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—AKT1—epilepsy syndrome	1.42e-07	1.41e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—APOE—epilepsy syndrome	1.42e-07	1.41e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—RELA—epilepsy syndrome	1.41e-07	1.4e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—MMP9—epilepsy syndrome	1.41e-07	1.4e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—JUN—epilepsy syndrome	1.4e-07	1.39e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—AKT1—epilepsy syndrome	1.39e-07	1.37e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—MTOR—epilepsy syndrome	1.38e-07	1.37e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.38e-07	1.37e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.37e-07	1.36e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—AKT1—epilepsy syndrome	1.37e-07	1.36e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—TH—epilepsy syndrome	1.36e-07	1.35e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—MMP9—epilepsy syndrome	1.36e-07	1.35e-06	CbGpPWpGaD
Bosutinib—FYN—Disease—AKT1—epilepsy syndrome	1.34e-07	1.33e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—AKT1—epilepsy syndrome	1.33e-07	1.32e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—SRC—epilepsy syndrome	1.3e-07	1.29e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—AKT1—epilepsy syndrome	1.29e-07	1.28e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—AKT1—epilepsy syndrome	1.27e-07	1.26e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CASP3—epilepsy syndrome	1.27e-07	1.26e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—VEGFA—epilepsy syndrome	1.27e-07	1.26e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—SRC—epilepsy syndrome	1.25e-07	1.24e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—AKT1—epilepsy syndrome	1.25e-07	1.24e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—JUN—epilepsy syndrome	1.24e-07	1.23e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—VEGFA—epilepsy syndrome	1.22e-07	1.21e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—POMC—epilepsy syndrome	1.22e-07	1.21e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—AKT1—epilepsy syndrome	1.21e-07	1.2e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—AKT1—epilepsy syndrome	1.2e-07	1.2e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—MMP9—epilepsy syndrome	1.2e-07	1.19e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—AKT1—epilepsy syndrome	1.15e-07	1.14e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.14e-07	1.13e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—AKT1—epilepsy syndrome	1.14e-07	1.13e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.12e-07	1.11e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—AKT1—epilepsy syndrome	1.11e-07	1.1e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—ALB—epilepsy syndrome	1.11e-07	1.1e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.09e-07	1.08e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—VEGFA—epilepsy syndrome	1.08e-07	1.07e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—AKT1—epilepsy syndrome	1.07e-07	1.06e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.02e-07	1.01e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—AKT1—epilepsy syndrome	9.94e-08	9.87e-07	CbGpPWpGaD
Bosutinib—SRC—Disease—AKT1—epilepsy syndrome	9.84e-08	9.77e-07	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—PTGS2—epilepsy syndrome	9.7e-08	9.63e-07	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—AKT1—epilepsy syndrome	9.7e-08	9.63e-07	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—AKT1—epilepsy syndrome	9.5e-08	9.43e-07	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—AKT1—epilepsy syndrome	9.35e-08	9.28e-07	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—AKT1—epilepsy syndrome	9.3e-08	9.23e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—AGT—epilepsy syndrome	8.9e-08	8.84e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—APOE—epilepsy syndrome	8.72e-08	8.66e-07	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—AKT1—epilepsy syndrome	8.08e-08	8.02e-07	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—AKT1—epilepsy syndrome	7.78e-08	7.73e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—POMC—epilepsy syndrome	7.49e-08	7.44e-07	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—AKT1—epilepsy syndrome	6.89e-08	6.84e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ALB—epilepsy syndrome	6.83e-08	6.78e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	5.98e-08	5.93e-07	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—AKT1—epilepsy syndrome	4.88e-08	4.84e-07	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—AKT1—epilepsy syndrome	3e-08	2.98e-07	CbGpPWpGaD
